Leaflet PINEX ANTITUSIV 1.5mg / ml syrup

Indicated for: dry cough

Route of administration: oral

Substance: butamirat (expectorant)

ATC: R05DB13 (Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants)

Butamirate is a medication used for the treatment of dry, non-productive cough. It acts as a central antitussive, inhibiting the cough reflex at the central nervous system level without causing dependency.

The medication is taken orally, in the form of syrup or tablets, as directed by a doctor. The dosage is adjusted based on the patient's age and weight.

Common side effects include drowsiness, dizziness, and nausea. In rare cases, allergic reactions such as skin rashes or breathing difficulties may occur.

Butamirate is not recommended for pregnant women during the first trimester or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other medications being used to avoid drug interactions.

General data about PINEX ANTITUSIV 1.5mg / ml

  • Substance: butamirat
  • Date of latest medicines list: 01-07-2015
  • Product code: W61741001
  • Concentration: 1.5mg / ml
  • Pharmaceutical form: syrup
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

  • Manufacturer: BALKANPHARMA TROYAN AD - BULGARIA
  • Holder: ACTAVIS GROUP PTC EHF. - ISLANDA
  • Number: 7632/2015/01
  • Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-6 months

Pharmaceutical forms available for butamirat

Concentrations available for butamirat

  • 1.5mg/ml
  • 5mg/ml
  • 7.5mg/5ml